Axcan Pharmaceuticals
Mont-saint-hilaire
About Axcan Pharmaceuticals
Axcan Pharma markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices, and multivitamin supplements. The company also provides products for active ulcerative proctitis, liver diseases, pancreatic diseases, cystic fibrosis, shwachman-diamond syndrome, chronic obstructive pulmonary disease, HIV/AIDS, and cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Series Unknown (Jan 2000)
- Website: axcan.com
Canonical: https://fsome.com/organization/axcan-pharmaceuticals-3049771 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.